This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07197/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07197/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB07197/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07197/identifier/pdb/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07197/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07197
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB07197 n14:DB07197
dcterms:title
4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID
adms:identifier
n6:9547958 n7:99443668 n8:DB07197 n9:694 n13:7826889
n3:IUPAC-Name
n4:271B5388-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B538E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B538D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B538A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B538B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B538C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5386-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5387-363D-11E5-9242-09173F13E4C5 n4:271B5384-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5385-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5394-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5395-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B538F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5390-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5392-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5391-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5393-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B539A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B539C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B539D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5399-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5398-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B539B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5389-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5396-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5397-363D-11E5-9242-09173F13E4C5